Close

Qualicaps to invest $26m for Whitsett facility expansion

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Onyx Scientific Boosts API Manufacturing Capacity in UK

Onyx Scientific, a global small molecule CDMO, is investing...

Neuland Expands Peptide Manufacturing Capacity in India

Neuland Laboratories is accelerating its peptide manufacturing expansion, with...

Upstream Process Optimization for Biologics Production Efficiency

The efficiency of biologics production is fundamentally determined at...
- Advertisement -

Pharmaceutical manufacturer Qualicaps will invest $26m to expand its facility in Whitsett, North Carolina in the US.

Under the expansion plans, the firm will also add additional 100,000 ft² building space. The project will be funded by the Guilford County Board of Commissioners and the State of North Carolina, which are providing economic development incentive grants of $272,805 and $235,000 respectively.

Greensboro Economic Development Alliance president Dan Lynch said Qualicaps decision to expand their manufacturing operations validates the firm’s industry cluster strategy.

“Qualicaps represents two of our five clusters; life science and innovative manufacturing. By expanding in Guilford County they are able to benefit from our skilled workforce and leverage comprehensive training programs through GTCC,” Lynch added.

Qualicaps is a wholly owned subsidiary of Qualicaps Group, which is a manufacturer and supplier of two-piece medical and nutrition grade gelatin capsules.

 

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Onyx Scientific Boosts API Manufacturing Capacity in UK

Onyx Scientific, a global small molecule CDMO, is investing...

Neuland Expands Peptide Manufacturing Capacity in India

Neuland Laboratories is accelerating its peptide manufacturing expansion, with...

Upstream Process Optimization for Biologics Production Efficiency

The efficiency of biologics production is fundamentally determined at...

mRNA Manufacturing Platforms for Advanced Therapy Scalability

The rapid development of messenger RNA technology has necessitated...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »